Under-Eye Hollows: What Dermal Filler Can (and Can't) Do

"You look tired" — said to you on a day you actually slept well — is one of the more frustrating comments patients bring up when we talk about under-eye hollows, also called tear troughs. That groove between the lower eyelid and the cheek can create a shadow that reads as fatigue regardless of how much sleep you're actually getting, and no amount of concealer fully hides it. Dermal filler is one of the more effective options for this specific concern, but it's also one of the more technically demanding areas to treat safely, given how close it sits to delicate eye anatomy. Here's an honest look at what the research shows, and what safety considerations are worth understanding before you book.

Why Under-Eye Hollows Form

•          Volume loss. The fat pad that normally cushions the area beneath the eye thins with age, and the underlying bone can also remodel slightly, both of which deepen the hollow.

•          Thin, delicate skin. Skin in this area is some of the thinnest on the face, so blood vessels and shadowing show through more easily than elsewhere.

•          Genetics and structure. Some people are simply born with a more pronounced tear trough or a naturally recessed cheek, independent of age.

•          Sleep, allergies, and fluid retention can create puffiness just below the hollow, which can actually make the shadow look more pronounced by contrast, even though these aren't the root cause of true structural hollowing.

How Dermal Filler Addresses This

Hyaluronic acid filler works by physically restoring lost volume along the orbital rim, softening the transition between the lower eyelid and the cheek so the shadow that reads as "tired" is less pronounced. This area is almost always treated with a blunt-tipped cannula rather than a sharp needle, since a cannula can be guided around blood vessels rather than through them, and injections are placed deep, close to the bone, in small amounts with frequent reassessment.

What the Research Shows

•          A 333-patient, multicenter, randomized, evaluator-blinded trial compared hyaluronic acid filler (via needle or cannula) against no treatment for moderate-to-severe under-eye hollowing. At the 3-month primary endpoint, 87.4% of treated patients were rated as responders, compared with 17.7% of untreated controls. Patient-reported satisfaction scores were also substantially higher in the treatment group. At 12 months, 63.5% of treated patients still showed a treatment response, and an optional touch-up at that point extended visible improvement through 18 months for most patients (Biesman et al., Aesthetic Surgery Journal, 2024).

•          The same trial reported that about 12.7% of patients experienced a generally mild adverse event, with a notably lower rate in the needle-injection group (4.9%) than the cannula group (20.9%) — a useful reminder that technique and delivery method both affect the side-effect profile, not just the product itself.

•          A clinical overview from ophthalmology specialists (who, unlike most injectors, operate directly on eye anatomy) emphasizes that patients with very thin, inelastic under-eye skin are often poor candidates, since fillers can look lumpy or show a bluish discoloration through thin skin (called the Tyndall effect) rather than blending smoothly. They also note that with careful technique, results commonly last about a year, with some patients seeing results maintained 5 to 7 years (Doran, EyeNet Magazine / American Academy of Ophthalmology, 2014, based on interviews with oculoplastic specialists at UCLA, UC San Diego, and Bascom Palmer).

I want to be direct about the safety side of this conversation, because it matters more here than in almost any other injection area: while overwhelmingly rare, the most serious possible complication from filler anywhere on the face is accidental injection into a blood vessel, which near the eye carries a rare but serious risk of vision changes. This is exactly why cannula technique, slow injection, small volumes, and an injector who is trained to recognize and respond immediately to any warning signs matter so much in this specific area. It's not a reason to avoid the treatment, but it is a reason to be selective about who performs it.

Am I a Good Candidate?

•          Good candidates typically have: a visible hollow or shadow with reasonably elastic, not paper-thin, under-eye skin, realistic expectations about softening rather than completely erasing the hollow, and no active eye infection or unmanaged bleeding disorder.

•          Caution or non-candidacy includes: very thin or crepey under-eye skin (higher risk of visible lumps or Tyndall effect), significant under-eye puffiness or fat prolapse that filler could worsen rather than improve, pregnancy or breastfeeding, and a known hypersensitivity to hyaluronic acid products.

•          An in-person exam matters more here than almost anywhere else on the face, since the right treatment (or the decision not to treat with filler at all) genuinely depends on your specific anatomy.

What to Expect: Timeline

•          Day of treatment: Mild swelling and possible bruising are common in this thin-skinned area, more so than in other facial regions.

•          Days 3–7: Initial swelling typically resolves, revealing a closer look at final results (results can look different mid-swelling than they will once settled).

•          Weeks 2–4: Filler fully settles and integrates with surrounding tissue.

•          12 months: Typical point to reassess and consider a touch-up, per the research above, though some patients maintain results longer.

If under-eye hollows are something you've been wanting an honest opinion on, I'd genuinely rather examine your specific anatomy in person and tell you if filler is or isn't the right fit than treat everyone the same way. Come see me for a consultation here in Henderson, and we'll figure out what actually makes sense for your face.

About the Author

Bianca Camille Fong, APRN, FNP-BC is a board-certified Family Nurse Practitioner and the Founder & CEO of Blanqa Medspa in Henderson, NV, as well as Fong Precision Care. She provides microneedling, wrinkle relaxer, dermal filler, and a full range of aesthetic and wellness treatments, with a focus on safe, evidence-informed care and realistic outcomes.

Blanqa Medspa

1485 W Warm Springs Rd, Suite 109B, Henderson, NV 89014

Phone: 702-997-6764  |  Email: hello@blanqaLV.com

Book a consultation: https://book.prospyrmed.com/8b132bf5-7541-4ac5-a6d0-d48e94745633/select-service

“Confidence for Your Skin, Elevate Your Glow.”

Sources

•          Varani, J., Dame, M.K., Rittie, L., et al. (2006). Decreased Collagen Production in Chronologically Aged Skin: Roles of Age-Dependent Alteration in Fibroblast Function and Defective Mechanical Stimulation. American Journal of Pathology, 168(6), 1861–1868.

•          Ablon, G. (2018). Safety and Effectiveness of an Automated Microneedling Device in Improving the Signs of Aging Skin. Journal of Clinical and Aesthetic Dermatology, 11(8), 29–34.